Hubspot names Cleerly Among 40 AI Startups To Watch Out For in 2023

Hubspot names Cleerly Among 40 AI Startups To Watch Out For in 2023

Hubspot, an industry-leading software provider of tools that link marketing, sales and customer service, names Cleerly as one of the top 40 startups to watch in 2023. 

Hubspot listed Cleerly for it's innovative approach to supporting physicians in heart disease diagnosis and treatment. Read the full article HERE.
 

 

Cardiovascular Blind Spots and How Cleerly Is Changing the Game

Cardiovascular Blind Spots and How Cleerly Is Changing the Game

In The Future of Medicine Podcast, Aaron Wenzel, MD, and Jennifer Justus, MSN, APRN, FNP-C dive into how Cleerly has revolutionized their ability to...

Read More
AI Leading the Way to More Precise Diagnostics and Disease Risk Prediction

AI Leading the Way to More Precise Diagnostics and Disease Risk Prediction

Inside Precision Medicine features our Chief Scientific Officer, Dr. Udo Hoffmann, on how AI has changed CT imaging and the TRANSFORM trial that may...

Read More
Digital Health 50: The Most Promising Digital Health Companies of 2023

Digital Health 50: The Most Promising Digital Health Companies of 2023

Selected from more than 10,000 private healthcare companies, Cleerly is named one of CB Insight’s Digital Health 50 based on R&D, Mosaic scores,...

Read More
The Future of Cardiology with Dr. James K. Min

The Future of Cardiology with Dr. James K. Min

Cleerly founder and CEO Dr. James K. Min talks with Kayla Barnes, a certified brain health and human optimization coach, on the Brain Biohacking...

Read More
I Can See Cleerly Now. Patient Says Scan Results Were ‘Eye-Opening’

I Can See Cleerly Now. Patient Says Scan Results Were ‘Eye-Opening’

Medtech Insights explains why seemingly healthy patients, like Sharon Bruno, can receive a zero on a coronary calcium scan but discover through...

Read More
A Personalized Care Pathway for Heart Attack Prevention

A Personalized Care Pathway for Heart Attack Prevention

In Today’s Medical Developments, Cleerly founder and CEO Dr. James K. Min explains why the current approach to cardiovascular care is flawed — and...

Read More